Insulet Reappoints Michael R. Minogue to Board

PUBT · 18h ago
Insulet Reappoints Michael R. Minogue to Board
  • Insulet appointed Michael R. Minogue to its board on November 19, 2026, effective November 20, 2026.
  • Minogue will serve as a Class I director with a term expiring at the 2029 annual stockholders meeting.
  • He previously served from August 2017 until September 2026, resigning to focus on his candidacy for governor of Massachusetts.
  • Minogue was Abiomed’s chairman, president and CEO from 2004 until its sale in December 2022.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insulet Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001145197-26-000195), on November 20, 2026, and is solely responsible for the information contained therein.